Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$122.71 - $146.91 $24.4 Million - $29.2 Million
199,100 New
199,100 $28.4 Million
Q4 2023

Feb 14, 2024

SELL
$87.78 - $105.45 $877,800 - $1.05 Million
-10,000 Reduced 50.0%
10,000 $1.03 Million
Q2 2023

Aug 14, 2023

BUY
$155.98 - $172.65 $1.98 Million - $2.19 Million
12,700 Added 173.97%
20,000 $3.24 Million
Q1 2023

May 15, 2023

BUY
$132.34 - $159.14 $966,082 - $1.16 Million
7,300 New
7,300 $1.16 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $238B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.